ArticleCureus2025
The "Vulnerable" in the G7's Vision: Children With Medical Complexities and the Call for Specific Strategies.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The G7 Hiroshima Summit (May 19-21, 2023) established the "G7 Hiroshima Vision for Fair Access to Medical Countermeasures (MCMs)", which includes vaccines, drugs, and antidotes for chemical, biological, radiological, and nuclear emergencies. The Summit also led to the creation of the "Medical Countermeasures Delivery Partnership." This initiative aims to ensure equitable access to MCMs, emphasizing principles like equity, inclusivity, efficiency, affordability, quality, accountability, agility, and speed. Japan's extensive experience positions it to lead globally in developing support systems for vulnerable populations, particularly children with medical complexities (CMCs). Despite this, the Summit's discussions lacked specificity in addressing these children's unique needs. Advances in medical technology have increased the number of CMCs, highlighting the importance of home-based advanced care. Our experience shows that CMCs can participate in activities such as excursions and hikes with proper preparations, including adequate oxygen and electricity and broader societal support. Recognizing CMCs as unique community members is crucial for promoting social justice, human rights, and societal innovation. The G7 communique's vague reference to 'vulnerable people' underscores the need for more precise and individualized approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.